Sign in
4

Changes in Ownership

Pyxis Oncology, Inc. Filed Acc 0001209191-23-060006

Options or other derivatives

  • Chief Medical Officer acquired 554,392 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kobayashi Ken · Chief Medical Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-12-29 Grant or award : show line 1 in the form Stock Option (Right to Buy) +443,514 443,514 D
2023-12-29 Grant or award : show line 2 in the form Stock Option (Right to Buy) +110,878 110,878 D
Loading xslF345X05/doc4.xml…